Quantcast

Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment

April 30, 2009

NEW YORK and NASSAU, The Bahamas, April 30 /PRNewswire-FirstCall/ — Prospero Group (PRPG) invested into the Private Placement Plan of Fincor (FINC) through a 1:1 share split. Prospero Group a leading company in the field of Water Technologies enlarges thru Fincor its portfolio with the new ACTRx Malaria and Dengue fever treatment. Fincor also acquired the WETTECH and Advanced Cavitation Technologies.

Prospero Group enlarges its technology portfolio with ACTRx, which combines several natural drugs to fight Malaria and Dengue fever. Prospero Group’s largest shareholder, Fincor acquired a majority on ACTRx International Inc. to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services.

Both Malaria and Dengue fever appear in the human landscape and seem to have only nebulous solutions that work sporadically in over one half of the countries in the world. Yet there are countries that have enjoyed the disappearance of both of these mosquito born diseases. Prospero Group’s intention is to research, review and objectively resolve the issues that keep these diseases active in our global society.

Fincor also acquired WETTECH marketed as Prospero Water Technologies and the Advanced Cavitation Technology.

Prospero Group intends to make further strategic acquisitions of proven, reliable and innovative technologies to its portfolio.

It was decided by the Board Members of Prospero Group on Friday, April 24, 2009 to invest into the Private Placement Plan of Fincor Inc. through a 1:1 share split of Prospero Group shareholdings.

About Prospero Group: Prospero Group is a U.S. and Bahamian technology development company whose primary focus is developing and producing technologies for potable water and alternative energy systems. Our market developments are concentrated in The Bahamas, United States of America, Latin America, Europe and Far East. One of the actual projects is to enable customers to sell “Green” water and energy products. The basis of the Prospero Water Technologies campaign will be its Advanced Cavitation Technology (ACT), “WETTECH”, Planets Purest Water and other Air Water generating machines.

About Fincor Inc.: Fincor Inc. is a technology and pharmaceutical company. It has recently acquired ACTRx International Inc. which produces Malaria and Dengue fever drugs in order to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services. Fincor Inc. also acquired Advanced Cavitation Technology (“WETTECH”), which produces 1000 gallons (200 liters) per hour of high purity distilled water. Using this technology, consistently delivers the highest purity product water at the lowest overall cost with a minimum of maintenance.

Allowing the liquid to become the heat source, rather than a hot surface as in conventional applications eliminates the problems of scale build-up and fouling associated with the heating of impure liquids. So the device provides efficient, simple, inexpensive and reliable sources of distilled potable water for residential, commercial and industrial use. The Cavitation Technology operates at a very low operating cost and is the only water purification of its type to be fully clean-in-place (CIP) capable at such large capacity of delivering potable water.

www.prospero-group.com

SOURCE Prospero Group


Source: newswire



comments powered by Disqus